These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8943063)

  • 1. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.
    Kinter AL; Ostrowski M; Goletti D; Oliva A; Weissman D; Gantt K; Hardy E; Jackson R; Ehler L; Fauci AS
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14076-81. PubMed ID: 8943063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
    Casoli C; Vicenzi E; Cimarelli A; Magnani G; Ciancianaini P; Cattaneo E; Dall'Aglio P; Poli G; Bertazzoni U
    Blood; 2000 May; 95(9):2760-9. PubMed ID: 10779418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.
    Moriuchi H; Moriuchi M; Combadiere C; Murphy PM; Fauci AS
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15341-5. PubMed ID: 8986813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K; Bentsman G; Chess L; Volsky DJ
    J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
    J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.
    Leith JG; Copeland KF; McKay PJ; Richards CD; Rosenthal KL
    AIDS; 1997 Apr; 11(5):575-80. PubMed ID: 9108938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
    J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
    Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
    Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals.
    Pinto LA; Williams MS; Dolan MJ; Henkart PA; Shearer GM
    Eur J Immunol; 2000 Jul; 30(7):2048-55. PubMed ID: 10940894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.
    Lewis MJ; Gautier VW; Wang XP; Kaplan MH; Hall WW
    J Immunol; 2000 Oct; 165(7):4127-32. PubMed ID: 11034425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.
    Jansson M; Popovic M; Karlsson A; Cocchi F; Rossi P; Albert J; Wigzell H
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15382-7. PubMed ID: 8986820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects.
    Rubbert A; Weissman D; Combadiere C; Pettrone KA; Daucher JA; Murphy PM; Fauci AS
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):63-9. PubMed ID: 8989428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals.
    Kakkanaiah VN; Ojo-Amaize EA; Peter JB
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):499-502. PubMed ID: 9665956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines.
    Dolei A; Biolchini A; Serra C; Curreli S; Gomes E; Dianzani F
    AIDS; 1998 Jan; 12(2):183-90. PubMed ID: 9468367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative investigation of CC chemokines and SIV suppressor factors generated by CD8+ and CD4+ T cells and CD14+ monocytes.
    Babaahmady K; Bergmeier LA; Whittall T; Singh M; Wang Y; Lehner T
    J Immunol Methods; 2002 Jun; 264(1-2):1-10. PubMed ID: 12191503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production.
    Greco G; Barker E; Levy JA
    AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1407-11. PubMed ID: 9824318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
    De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.